SSH Medical (ASX:SSH) re-listed today on the ASX following a capital raising of AUD$4.26 million and the acquisition of unlisted Brisbane-based materials sciences specialist Bio-Layer. [ + ]

University of Queensland researchers have identified a protein that is crucially involved in how memories are stored and processed, paving the way for new strategies to treat conditions of certain mental disorders.

The European Bioinformatics Institute and Flanders Interuniversity Institute for Biotechnology-Ghent University have launched the PRoteomics IDEntifications database (PRIDE; www.ebi.ac.uk/pride). PRIDE allows researchers who work in the field of proteomics - the large-scale study of proteins - to share information much more readily than was previously possible. This will allow them to exploit the growing mass of information on how the body's complement of proteins is altered in many disease states, paving the way towards new predictive and diagnostic methods in medicine.

Five years ago, x-ray crystallography made it possible for the first time to study ribosomes in cells, where the synthesis of proteins takes place. But it hasn't been understood just how amino acids are joined together to form proteins. Now researchers at Uppsala University have discovered the only possible mechanism and have used it to explain a number of biochemical experiments.

Brisbane medical diagnostics developer Panbio (ASX:PBO) has successfully completed a seven-month search for a new CEO in what executive chairman Jim Kalokerinos has described as a "longer process than hoped." [ + ]

Melbourne-based gene testing company Genetic Technologies (ASX:GTG, NASDAQ:GENE) appears to be nearing settlement of its long-running court case against US rival Applera Corp over Applera's refusal to take a licence to use GTG's patents on the use of so-called 'junk' DNA markers for gene testing. [ + ]

Stem Cell Sciences (AIM:STEM, SCS) has granted US-based biopharmaceutical company Lexicon Genetics an exclusive license to its Internal Ribosome Entry Site (IRES) technology for genetically modified mice. [ + ]

Perth-based Regenera (ASX:RGA) has revealed plans to acquire US-based Advanced Ocular Systems (AOS) for US$31 million (AUD$40 million) in a plan to expand its portfolio of ophthalmic products and technologies. [ + ]

The two largest shareholders in Singapore-based, ASX-listed biopharmaceutical company SciGen (ASX:SIE), SciTech Medical and Bioton, have entered into a share exchange agreement which may result in Bioton gaining a 44.7 per cent equity share in SciGen. [ + ]

Perth-based Resonance Health Group (ASX:RHT) will progress to being a "two-product company" with the commercialisation of a new test for liver fibrosis, the company's managing director said this week. [ + ]

Probiomics (ASX:PCC), formerly VRI BioMedical, has launched a share purchase plan (SPP) which could raise AUD$2 million if fully subscribed. [ + ]

The Victorian government has presented a birthday gift for Melbourne's Walter and Eliza Hall Institute for Medical Research: a AUD$50 million contribution towards the cost of a new seven-storey wing that will double the institute's size. [ + ]

Dr Caroline Gargett from Monash Institute of Medical Research (MIMR) has discovered adult stem cells in the uterus that can be grown into bone, muscle, fat and cartilage and her research has been hailed as a major medical and scientific development by international reproduction experts.

Alchemia (ASX:ACL) has raised AUD$14.6 million through a share placement and will commence a share purchase plan (SPP) to offer an additional $5 million to existing shareholders. [ + ]

Bionomics (ASX:BNO) has licensed two genetic tests for the diagnosis of epilepsy to US giant Laboratory Corporation of America. [ + ]